<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04787757</url>
  </required_header>
  <id_info>
    <org_study_id>ARTERY/08/2021</org_study_id>
    <nct_id>NCT04787757</nct_id>
  </id_info>
  <brief_title>Autonomous Robotics for Transcatheter Cardiac Procedures</brief_title>
  <acronym>ARTERY</acronym>
  <official_title>Autonomous Robotics for Transcatheter dEliveRy sYstems</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Università Vita-Salute San Raffaele</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Politecnico di Milano</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Scuola Superiore Di Studi Universitari E Di Perfezionamento Sant'Anna</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>KU Leuven</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>SwissVortex</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Artiness SRL</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>FBGS</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>IRCCS Ospedale San Raffaele</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Università Vita-Salute San Raffaele</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cardiovascular diseases represent the most common cause of death worldwide. Percutaneous&#xD;
      approaches with intravascular catheters are pivotal, since they allow to treat patients with&#xD;
      high perioperative risks. However, catheter-based treatments require steep learning curves&#xD;
      and are characterized by poor ergonomics and exposure to damaging radiation. ARTERY will&#xD;
      offer a radiation-free approach based on shared-autonomy robotic catheters, with increased&#xD;
      user engagement and easy interaction. Intraprocedural three-dimensional echocardiography as&#xD;
      well as computed tomography images obtained during usual clinical practice will provide&#xD;
      artificial intelligence algorithms that will turn catheter navigation to a simple task.&#xD;
      Optical and electromagnetic sensing techniques will ensure a superior view upon the&#xD;
      cardiovascular anatomy and will guide the autonomous catheter upon the interventionist&#xD;
      supervision, who will be able to take over control at any instant.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 15, 2021</start_date>
  <completion_date type="Anticipated">March 2024</completion_date>
  <primary_completion_date type="Anticipated">March 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Identification of key procedural elements that will benefit from the technological developments introduced by ARTERY by collecting intraprocedural images</measure>
    <time_frame>Intraoperative period</time_frame>
    <description>Number of patients undergoing percutaneous cardiac procedures</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Mitral Valve Disease</condition>
  <condition>Heart Valve Diseases</condition>
  <condition>Structural Heart Abnormality</condition>
  <arm_group>
    <arm_group_label>Percutaneous cardiac procedures</arm_group_label>
    <description>Patients undergoing percutaneous cardiac procedures</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Percutaneous cardiac procedure</intervention_name>
    <description>Collection and analysis of intraprocedural information to provide artificial intelligence algorithms</description>
    <arm_group_label>Percutaneous cardiac procedures</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Candidates to percutaneous cardiac defects repair&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  adult patients&#xD;
&#xD;
          -  patients admitted to hospital undergoing percutaneous cardiac procedure&#xD;
&#xD;
          -  patients able to give informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  age &lt;18 years&#xD;
&#xD;
          -  refuse to give informed consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Università Vita-Salute San Raffaele</name>
      <address>
        <city>Milano</city>
        <state>MI</state>
        <zip>20132</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giovanni Landoni, MD, Associate Professor</last_name>
      <phone>+39022643</phone>
      <phone_ext>6151</phone_ext>
      <email>landoni.giovanni@hsr.it</email>
    </contact>
    <contact_backup>
      <last_name>Paolo Denti, MD</last_name>
      <phone>+39022643</phone>
      <phone_ext>5313</phone_ext>
      <email>denti.paolo@hsr.it</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>February 26, 2021</study_first_submitted>
  <study_first_submitted_qc>March 4, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 9, 2021</study_first_posted>
  <last_update_submitted>March 15, 2021</last_update_submitted>
  <last_update_submitted_qc>March 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Università Vita-Salute San Raffaele</investigator_affiliation>
    <investigator_full_name>Giovanni Landoni</investigator_full_name>
    <investigator_title>MD, Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Valve Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

